Join
Live feed
·
INSIDERFilingvia Quantisnow
Generate Biomedicines Inc. logo

Chief Executive Officer Nally Michael converted options into 658,327 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
GENB· Generate Biomedicines Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GENB (Generate Biomedicines Inc.) and more on Quantisnow.